These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36273736)

  • 41. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
    Seiwert TY; Melotek JM; Blair EA; Stenson KM; Salama JK; Witt ME; Brisson RJ; Chawla A; Dekker A; Lingen MW; Kocherginsky M; Villaflor VM; Cohen EE; Haraf DJ; Vokes EE
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):21-9. PubMed ID: 27511844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcomes and safety after reirradiation in locally recurrent nasopharyngeal carcinoma in a non-endemic area.
    Boustani J; Ruffier A; Moya-Plana A; Tao Y; Nguyen F; Even C; Berthold C; Casiraghi O; Temam S; Blanchard P
    Strahlenther Onkol; 2021 Mar; 197(3):188-197. PubMed ID: 32514613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic impact of pathological complete remission after preoperative irradiation in patients with locally advanced head and neck squamous cell carcinoma: re-analysis of a phase 3 clinical study.
    Wang K; Yi J; Huang X; Qu Y; Luo J; Xiao J; Zhang S; Tang Y; Liu W; Xu G; Gao L; Xu Z; Liu S; Wang X
    Radiat Oncol; 2019 Dec; 14(1):225. PubMed ID: 31831042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience.
    Akbaba S; Heusel A; Mock A; Held T; Lang K; Hoerner-Rieber J; Forster T; Katayama S; Kargus S; Rieken S; Plinkert P; Herfarth K; Debus J; Adeberg S
    Oral Oncol; 2019 Oct; 97():115-123. PubMed ID: 31494395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reirradiation of head and neck cancer: Long-term disease control and toxicity.
    Bots WTC; van den Bosch S; Zwijnenburg EM; Dijkema T; van den Broek GB; Weijs WLJ; Verhoef LCG; Kaanders JHAM
    Head Neck; 2017 Jun; 39(6):1122-1130. PubMed ID: 28263446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study.
    Sumita K; Harada H; Asakura H; Ogawa H; Onoe T; Murayama S; Nakamura S; Tanigawa N; Takahashi T; Nishimura T
    Radiat Oncol; 2016 Aug; 11():104. PubMed ID: 27485533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis.
    Grambozov B; Nussdorfer E; Kaiser J; Gerum S; Fastner G; Stana M; Gaisberger C; Wass R; Studnicka M; Sedlmayer F; Zehentmayr F
    Curr Oncol; 2021 May; 28(3):1835-1846. PubMed ID: 34068043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience.
    Held T; Windisch P; Akbaba S; Lang K; El Shafie R; Bernhardt D; Plinkert P; Kargus S; Rieken S; Herfarth K; Debus J; Adeberg S
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):803-811. PubMed ID: 31349059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma.
    Rambeau A; Bastit V; Thureau S; Thariat J; Moldovan C; Roge M; Babin E; Gery B; Di Fiore F; Florescu C; Clatot F
    Oral Oncol; 2019 Jun; 93():46-51. PubMed ID: 31109695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck.
    Echevarria MI; Yang GQ; Chen DT; Kirtane K; Russell J; Kish J; Muzaffar J; Otto K; Padhya T; McMullen C; Patel K; Chung CH; Caudell JJ
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):341-347. PubMed ID: 37105404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.
    Dionisi F; Croci S; Giacomelli I; Cianchetti M; Caldara A; Bertolin M; Vanoni V; Pertile R; Widesott L; Farace P; Schwarz M; Amichetti M
    Acta Oncol; 2019 Sep; 58(9):1238-1245. PubMed ID: 31155998
    [No Abstract]   [Full Text] [Related]  

  • 52. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
    Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
    J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reirradiation for second primary or recurrent cancers of the head and neck: Dosimetric and outcome analysis.
    Garg S; Kilburn JM; Lucas JT; Randolph D; Urbanic JJ; Hinson WH; Kearns WT; Porosnicu M; Greven K
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E961-9. PubMed ID: 25993910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.
    McAvoy S; Ciura K; Wei C; Rineer J; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):819-27. PubMed ID: 25220718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial.
    Held T; Lang K; Regnery S; Weusthof K; Hommertgen A; Jäkel C; Tonndorf-Martini E; Krisam J; Plinkert P; Zaoui K; Freudlsperger C; Moratin J; Krauss J; Harrabi SB; Herfarth K; Debus J; Adeberg S
    Radiat Oncol; 2020 Aug; 15(1):190. PubMed ID: 32758267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 May; 13(1):86. PubMed ID: 29739417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.
    Tao Y; Faivre L; Laprie A; Boisselier P; Ferron C; Jung GM; Racadot S; Gery B; Even C; Breuskin I; Bourhis J; Janot F
    Radiother Oncol; 2018 Sep; 128(3):467-471. PubMed ID: 29784451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.
    Fayette J; Molin Y; Lavergne E; Montbarbon X; Racadot S; Poupart M; Ramade A; Zrounba P; Ceruse P; Pommier P
    Drug Des Devel Ther; 2015; 9():6203-10. PubMed ID: 26648696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.